#Biopharma #companies-Biopharma companies
#Russia #Syria #Turkey #Ukraine #Yemen #USA
Biopharma companies 3 Reasons to Watch Array Biopharma Inc. Seldom are the risks or the profit potential higher than investing in small-cap biotech. Here we examine what Array Biopharma is doing that other biotech companies aren’t that’s getting the attention of the biggest analysts in the business. It is no secret that the risks associated with pharmaceutical development are considerable. The cost to develop a novel drug often exceeds $1 billion. Many smaller biotechs support these high development costs by by offering licensing options to larger pharmaceutical companies in return for cash at certain development milestones. There are three essential ...
https://ift.tt/2NA6NzR
Comments
Post a Comment